Novartis Ag (NVS) EPS (Basic) (QoQ) (2009 - 2023)

Novartis Ag (NVS) EPS (Basic) (QoQ) (2009 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2023 -69.81%
Sep 30, 2023 454.68%
Jun 30, 2023 -68.06%
Mar 31, 2023 140.07%
Dec 31, 2022 -74.12%
Sep 30, 2022 -88.00%
Jun 30, 2022 247.43%
Mar 31, 2022 -90.01%
Dec 31, 2021 827.73%
Sep 30, 2021 -81.44%
Jun 30, 2021 582.10%
Mar 31, 2021 -74.12%
Dec 31, 2020 228.80%
Sep 30, 2020 -73.60%
Jun 30, 2020 -100.00%
Jun 30, 2019 2,549,104,305,879.42%
Mar 31, 2019 -851.07%
Dec 31, 2018 100.00%
Sep 30, 2018 -535.24%
Jun 30, 2018 20,128,790,926.17%